Stockreport

Passage Bio to Participate in Upcoming Investor Conferences

Passage Bio, Inc.  (PASG) 
PDF PHILADELPHIA, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on improving the lives of patients [Read more]